Kazuhito Morioka

Dr. Kazuhito Morioka

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2016 in Advanced Materials Technologies
Verified
Journal Article
Closed access
PDF file
Hiroki OtaHiroki Ota
Hiroki Ota
SESam Emaminejad
Sam Emaminejad
YGYuji Gao
Yuji Gao
AZAllan Zhao
Allan Zhao
EWEric Wu
Eric Wu
AJAli Javey
Ali Javey

10 June 2009 in Cancer Science
Verified
Journal Article
Open access
PDF file
KMKazuhito Morioka
Kazuhito Morioka
CTChizu Tanikawa
Chizu Tanikawa
KOKensuke Ochi
Kensuke Ochi
YDYataro Daigo
Yataro Daigo
TKToyomasa Katagiri
Toyomasa Katagiri
KMKoichi Matsuda
Koichi Matsuda
Osteosarcoma is the most prevalent bone malignant tumor in children and adolescents, and displays heterogeneous histology and high propensity for distant metastasis. Although adjuvant chemotherapy remarkably improved treatment outcome over the past few decades, prognosis for osteosarcoma patients with pulmonary metastasis is still unsatisfactory. To identify novel therapeutic targets for osteosarcoma, we investigated the gene expression profile of osteosarcomas by cDNA microarray analysis and found transactivation of receptor tyrosine kinase‐like orphan receptor 2 (ROR2) expression in the majority of osteosarcoma samples. Treatment of osteosarcoma cell lines with siRNA against ROR2 significantly inhibited cell proliferation and migration. We also identified wingless‐type MMTV integration site family, member 5B (WNT5B) as a putative ROR2 ligand and that the physiological interaction of WNT5B and ROR2 could enhance cell migration, indicating the possible roles of ROR2 and WNT5B in the metastatic property of osteosarcoma cells. Taken together, our findings revealed that the WNT5B/ROR2 signaling pathway is a promising therapeutic target for osteosarcoma. (Cancer Sci 2009; 100: 1227–1233)

24 January 2012 in Spinal Cord
Verified
Journal Article
Closed access
PDF file
KHK Hayakawa
K Hayakawa
ROR Okazaki
R Okazaki
KIK Ishii
K Ishii
TUT Ueno
T Ueno
NIN Izawa
N Izawa
TOT Ogata
T Ogata

10 July 2014 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
KHKentaro Hayakawa
Kentaro Hayakawa
RORentaro Okazaki
Rentaro Okazaki
KMKazuhito Morioka
Kazuhito Morioka
KNKozo Nakamura
Kozo Nakamura
STSakae Tanaka
Sakae Tanaka
TOToru Ogata
Toru Ogata

4 May 2017 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
VPValentina Pedoia
Valentina Pedoia
JHJenny Haefeli
Jenny Haefeli
KMKazuhito Morioka
Kazuhito Morioka
HTHsiang‐Ling Teng
Hsiang‐Ling Teng
LNLorenzo Nardo
Lorenzo Nardo
SMSharmila Majumdar
Sharmila Majumdar

21 August 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KMKazuhito Morioka
Kazuhito Morioka
YMYotvat Marmor
Yotvat Marmor
JSJeffrey A. Sacramento
Jeffrey A. Sacramento
ALAmity Lin
Amity Lin
TSTiffany Shao
Tiffany Shao
CBChelsea S. Bahney
Chelsea S. Bahney
Polytraumatic injuries, specifically long bone fracture and traumatic brain injury (TBI), frequently occur together. Clinical observation has long held that TBI can accelerate fracture healing, yet the complexity and heterogeneity of these injuries has produced conflicting data with limited information on underlying mechanisms. We developed a murine polytrauma model with TBI and fracture to evaluate healing in a controlled system. Fractures were created both contralateral and ipsilateral to the TBI to test whether differential responses of humoral and/or neuronal systems drove altered healing patterns. Our results show increased bone formation after TBI when injuries occur contralateral to each other, rather than ipsilateral, suggesting a role of the nervous system based on the crossed neuroanatomy of motor and sensory systems. Analysis of the humoral system shows that blood cell counts and inflammatory markers are differentially modulated by polytrauma. A data-driven multivariate analysis integrating all outcome measures showed a distinct pathological state of polytrauma and co-variations between fracture, TBI and systemic markers. Taken together, our results suggest that a contralateral bone fracture and TBI alter the local neuroinflammatory state to accelerate early fracture healing. We believe applying a similar data-driven approach to clinical polytrauma may help to better understand the complicated pathophysiological mechanisms of healing.